îæ€çŽ¢
îæ€çŽ¢
î
Neurosense Therapeutics Ltd
NRSNîãŠã©ãããªã¹ãã«è¿œå
0.465USD
-0.011-2.27%
çµå€Â 07-31 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
15.15Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
詳现æ å ± Neurosense Therapeutics Ltd äŒæ¥å
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltdã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãNRSN
äŒç€ŸåNeurosense Therapeutics Ltd
äžå Žæ¥Dec 09, 2021
æé«çµå¶è²¬ä»»è
ãCEOãBen-Noon (Alon)
åŸæ¥å¡æ°15
蚌åžçš®é¡Ordinary Share
決ç®ææ«Dec 09
æ¬ç€Ÿæåšå°11 Hamenofim St.
éœåžHERZLIYA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœIsrael
éµäŸ¿çªå·4672562
é»è©±çªå·97297996183
ãŠã§ããµã€ãhttps://www.neurosense-tx.com/
äŒæ¥ã³ãŒãNRSN
äžå Žæ¥Dec 09, 2021
æé«çµå¶è²¬ä»»è
ãCEOãBen-Noon (Alon)
Neurosense Therapeutics Ltdã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
ãããã質å
Neurosense Therapeutics Ltdã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îNeurosense Therapeutics Ltdã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ããMr. Alon Ben-Noon
Neurosense Therapeutics LtdïŒNRSNïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2026Q1æç¹ã§ãNeurosense Therapeutics Ltdã®æ ªåŒãä¿æããŠããæ©é¢ã¯33瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ367.79Kã§ãå
šäœã®1.04%ãå ããŠããŸãã2025Q4ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-2009158.00å¢å ããŠããŸãã